Working… Menu
Trial record 1 of 2 for:    urovant 3005
Previous Study | Return to List | Next Study

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04103450
Recruitment Status : Enrolling by invitation
First Posted : September 25, 2019
Last Update Posted : July 8, 2021
Information provided by (Responsible Party):
Urovant Sciences GmbH

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022